SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-041969
Filing Date
2021-08-12
Accepted
2021-08-12 15:19:36
Documents
46
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0621_orionbiotech.htm   iXBRL 10-Q 426707
2 CERTIFICATION f10q0621ex31-1_orionbiotech.htm EX-31.1 16744
3 CERTIFICATION f10q0621ex31-2_orionbiotech.htm EX-31.2 16786
4 CERTIFICATION f10q0621ex32-1_orionbiotech.htm EX-32.1 6630
5 CERTIFICATION f10q0621ex32-2_orionbiotech.htm EX-32.2 6652
  Complete submission text file 0001213900-21-041969.txt   3020867

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE oria-20210630.xsd EX-101.SCH 42619
7 XBRL CALCULATION FILE oria-20210630_cal.xml EX-101.CAL 21337
8 XBRL DEFINITION FILE oria-20210630_def.xml EX-101.DEF 182942
9 XBRL LABEL FILE oria-20210630_lab.xml EX-101.LAB 336753
10 XBRL PRESENTATION FILE oria-20210630_pre.xml EX-101.PRE 189091
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0621_orionbiotech_htm.xml XML 270086
Mailing Address 645 FIFTH AVENUE, 21ST FLOOR NEW YORK NY 10022
Business Address 645 FIFTH AVENUE, 21ST FLOOR NEW YORK NY 10022 212-303-7822
Orion Biotech Opportunities Corp. (Filer) CIK: 0001847416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40410 | Film No.: 211167179
SIC: 6770 Blank Checks
Office of Real Estate & Construction